In contrast to the majority of yeast RNA polymerase IItranscribed genes whose activities depend on upstream activation sequences (UASs), the Ty retrotransposons contain transcriptional control sequences downstream of the transcription start site (2) . These enhancer-like elements are distinct from UAS elements, since UAS elements do not activate transcription when located downstream of the mRNA initiation site (31, 66) . This finding suggests that Ty enhancer-mediated activation of transcription may involve novel regulatory factors or interactions.
Ty transcripts initiate in the 5Ј long terminal repeat and terminate in the 3Ј long terminal repeat, and they account for nearly 10% of the total poly(A) ϩ RNA of a haploid yeast cell (12) . A TATA element and a weak UAS have been identified upstream of the transcriptional start site (23, 41) . Downstream Ty regulatory regions have been defined by deletion analysis in both Ty1 and Ty2 elements (7-9, 15, 17, 23, 41, 70, 75) . These studies revealed that Ty transcription is regulated by a complex array of positively and negatively acting sequences located within the first 1 kb of the Ty element.
Previous genetic screens to identify mutations in Ty transcriptional regulators have exploited the effects of Ty insertion mutations on their target genes. Insertion of a Ty element into the promoter of a gene can disturb the transcriptional regulation of that gene, either increasing or decreasing its expression. Activation of adjacent gene transcription is seen only when the transcriptional orientation of the inserted Ty element is opposite that of the affected gene and is the simple consequence of the introduction of Ty regulatory elements upstream of the TATA element and transcriptional start site of that gene (reviewed in reference 2).
Mutations in the trans-acting SPT, TYE, and TEC (ROC) genes have been identified as suppressors of the effects of Ty insertion mutations on adjacent gene expression (4, 11, 18, 72, 73) . Many of these mutations also affect Ty transcription to some degree. Notably, most of the SPT and TYE genes encode global transcriptional regulators rather than DNA-binding proteins with specific binding sites in the Ty element (6, 34, 68, 69) , possibly because the functional redundancy of Ty regulatory sequences minimizes the impact of a mutation in any single regulator.
To identify specific Ty enhancer-binding proteins, we have focused on a small cluster of protein binding sites from within Ty1 elements and have studied it outside of its natural context. An internal Ty1 region known as block II was originally identified by its sequence similarity to the enhancer core of the DNA tumor virus simian virus 40 (SV40) (14) . When inserted upstream of a reporter gene, block II sequences isolated as a HpaI-Sau3A restriction fragment (fragment D) are capable of stimulating transcription (9) . Three proteins are known to interact with fragment D: the UAS-binding proteins Mcm1 and Rap1 (13, 27, 74) and a third unidentified protein or protein complex which was designated IBF (I-binding factor) because it interacted with sequences in the TaqI-Sau3A D subfragment called fragment I ( Fig. 1) (9, 27) .
IBF protects sequences between the Mcm1 and Rap1 binding sites and partially overlaps the Rap1 site ( Fig. 1) (9) . Mutations within the IBF binding site dramatically reduce the ability of fragment D to activate transcription but do not affect Rap1 or Mcm1 binding (27) . Thus, IBF activity is essential for fragment D-mediated transcriptional activation.
Using a genetic screen, we have identified mutations in trans-acting factors required for Ty1 fragment D to efficiently activate transcription. In addition to mutations in MCM1 and RAP1, several mutations were isolated in a single new gene. This gene, designated TEA1 (for Ty1 enhancer-mediated activation), encodes a Gal4-like zinc cluster protein that recognizes a CGGN 10 CCG partially palindromic binding site in the Ty1 element enhancer. Analysis of strains lacking and overexpressing TEA1 reveal its importance in activation via this site and demonstrate that Tea1 is one of several activators contributing to normal levels of Ty1 gene expression.
MATERIALS AND METHODS
Strains. Saccharomyces cerevisiae strains constructed for use in this work or previously existing in our laboratory are listed in Table 1 . JF1429 was constructed by disrupting the TEA1 locus in JF820 with the XhoI-XbaI fragment of pBG161 (see below and Table 2 ). The TYE7 locus of JF1224 was replaced with tye7⌬::URA3 by transformation with the DraI fragment of plasmid pT11-tye7⌬1 (gift of M. Ciriacy) (42) to yield JF1444. GGY1::171 was the gal4⌬ strain used for evaluating the activities of Gal4 fusion proteins (44) . The PUT3 locus of JF66 was replaced with the put3⌬::TRP1 allele by transformation with the 1.4-kb SnaBI plasmid of pDB101 (gift of M. Brandriss). The replacement of the wild-type loci with the disrupted alleles in strains JF1429, JF1444, and JF1445 was confirmed by Southern hybridization analysis.
Plasmids. Plasmids constructed for this work or previously existing in our collection are listed in Table 2 . Construction of the Ty1 D fragment (designated Ty1-D in plasmid descriptions) derivative clones in the CYC1-lacZ reporters pLG⌬312 and pLG670Z (32) has been previously described (27, 74) . The CGGbox mutant derivatives, pBG81 and pBG82, were constructed by oligonucleotidedirected mutagenesis (37) .
The structures of two plasmids, pBG122 and pBG127, from a genomic library and of two subclones (pBG128 and pBG156) bearing the TEA1 gene are shown in Fig. 2 . pBG161 is a derivative of pGEM5Zf (Promega) carrying a 1.5-kb ScaI deletion (amino acids [aa] 64 to 566) of the TEA1 gene marked with the LEU2 gene.
pBG184 is a derivative of pBG155 in which a BsrBI site was introduced at the predicted N terminus of Tea1 by site-directed mutagenesis (37) . The 2.4-kb BsrBI-XbaI pBG184 fragment encoding full-length Tea1 was then cloned into the SmaI-and XbaI-digested pGEX-KG (28) and pGEST (51) glutathione S-transferase (GST) fusion vectors to create pBG185 and pBG189, respectively. pBG187, a GST-Tea1 fusion consisting of Tea1 aa 3 to 232, was constructed by SalI digestion of pBG185 followed by partial HpaI digestion.
The GAL4-TEA1 fusions were constructed by using plasmid pMA424 (44) . pBG201 containing Tea1 aa 3 to 759 was constructed by ligating the 2.4-kb BsrBI-XbaI fragment from pBG183 into the Klenow enzyme-treated EcoRI site of pMA424. HpaI, DraI-, EcoRV-, and EagI-to-BamHI fragments from pBG183 were ligated into the Klenow enzyme-treated EcoRI site of pMA424 to create pBG176 to pBG179, respectively. pBG202 was constructed by inserting an NdeIXbaI fragment from pBG183 into a blunted BamHI site of pMA424, and pBG203 was constructed by inserting a BsrBI-NdeI fragment from pBG183 into a blunted EcoRI site of pMA424. pBG199 was constructed in several steps. Initially a BamHI fragment containing the ADH1 promoter, LexA DNA-binding domain (DBD) (aa 1 to 202), Gal4 (aa 74 to 881), and ADH1 transcription terminator isolated from pMA411 (58) was cloned into BglII-cut bacterial vector pSP72 (Promega), generating the intermediate plasmid, pBG196. pBG196 was digested with NarI, deleting most of GAL4 and everything upstream, leaving behind Gal4 aa 767 to 881. Into the NarI-deleted pBG196 was introduced a BglII-to-NdeI fragment including Tea1 aa 133 to 704 to form pBG198. Finally, an HpaI-to-BamHI fragment was isolated from pBG198 and introduced into EcoRI (blunt)-plus-BamHI-cut pMA424 to generate plasmid pBG199. Plasmid pMA210 containing the intact GAL4 gene under the control of the ADH1 promoter was used in these experiments as a control (44) .
The marked Ty1 plasmid, YCplys2-61Z, used to assess the effects of tea mutations on adjacent gene expression, was described previously (19) .
The TYE7 disruption plasmid, pT11-tye7⌬1 (gift of M. Ciriacy), and the PUT3 disruption plasmid, pDB101 (gift of M. Brandriss), were previously described (42, 45) . A LEU2 high-copy-number PUT3 plasmid was constructed by removing FIG. 1. Ty1 fragment D derivation and sequence. The Ty1 fragment D used in these studies was taken from the lys2-61 insertion, which consists of the Ty61 element inserted between the transcription start site and the ATG of the LYS2 gene as shown. The promoter for the Ty element is located in the left-hand repeat. Fragment D is located at position ϩ818 of the Ty element and was originally isolated as a HpaI-Sau3A fragment. This fragment contains a TaqI restriction site which subdivides it into fragments H and I as shown. Known binding sites for the Mcm1 (P), Rap1, and a1-␣2 diploid control protein complex (diploid) are shown above the sequence. Sequence similarity to the enhancer core region from within the 72-bp repeats of the DNA tumor virus SV40 is also noted. The binding site for IBF is deduced from DNase I protection experiments (9). a All reporters except pBG28 are based on plasmid pLG⌬312 (32) , which contains a 2m origin of replication and a URA3 selectable marker. This reporter contains the CYC1 UAS and CYC1 sequences downstream of the UAS. The CYC1 UAS in that plasmid was deleted and replaced by the elements indicated. pBG28 is based on plasmid pLG670Z (32) , which contains CYC1 sequences upstream as well as downstream of the UAS position. GAL4 constructs pBG176 to pBG179 and pBG199 to pBG203 are based on plasmid pMA424, which contains the 2m origin and HIS3 selectable marker (44) .
b Fusion based on plasmid pGEX-KG (28) . c Fusion based on shuttle plasmid pGEST (51) . d AD, activation domain including Gal4 aa 767 to 881. the 3.8-kb SnaBI fragment from pDB37 (gift of M. Brandriss) and subcloning it into SmaI-digested pRS425 (Stratagene). Media and genetic methods. All media were prepared as described by Sherman et al. (62) and included synthetic complete medium (SC) lacking one or more specific amino acids and rich medium (YPD). 5-Bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) plates were buffered with M9 salts (39) . X-Gal was added to a concentration of 75 g/ml. Plasmids were introduced into appropriate strains by lithium acetate-based transformation (35) .
Ethyl methanesulfonate mutagenesis. The wild-type yeast strain JF820 harboring the reporter plasmid pBG28 [UAS(Ty1-D)-CYC1-lacZ] was mutagenized with ethyl methanesulfonate according to published methods (40) , resulting in approximately 60% lethality. Mutagenized cells were plated on SC-Ura plates and incubated at 30ЊC for 4 days, after which they were replica plated to SC-Ura plates containing 75 g of X-Gal per ml. Colonies which remained white after 2 days incubation at 30ЊC were saved as putative candidates.
Preliminary genetic analysis. cis-acting mutations in pBG28 were eliminated by isolating Ura Ϫ colonies on plates containing 1 mg of 5-fluoroorotic acid per ml and retransforming them with pBG28. Retransformed mutants that did not exhibit the original white phenotype on SC-Ura medium containing X-Gal were discarded.
The ability of MCM1 or RAP1 to complement the tea mutations was tested by introducing plasmid pBG63 containing a functional MCM1 gene and pBG64 containing a functional RAP1 gene into each mutant. Mutants whose X-Gal phenotype was complemented by the MCM1 or RAP1 gene were discarded. The remaining mutants were backcrossed to the isogenic wild-type strain JF1224, and the resulting diploids were sporulated. Candidates that did not segregate 2:2 for the X-Gal phenotype were discarded. Mutants were then crossed by one another and sporulated. Linkage groups were assigned on the basis of the results of tetrad analysis.
␤-Galactosidase assays. Yeast protein extracts were prepared by glass bead lysis from cultures grown at 30ЊC and harvested at a density of 10 7 cells per ml. Extracts were cleared by centrifugation in all cases except for extracts prepared for measuring Ty1-lacZ activity (shown in Fig. 3A ), which were uncleared because the activity of these Ty-lacZ fusions is particulate (16a). ␤-Galactosidase activity was measured in Miller units (50) , and values were reported in relative units after normalization to the activity of an ACT1-lacZ control plasmid (pGY63) (74) expressed in wild-type strain JF820 and measured in each experiment as previously described (27) . Activities are the averages of at least 4 and up to 20 different transformants except where noted otherwise.
Cloning of the TEA1 gene. The original tea1-6 mutant was crossed successively three times with JF1224, an isogenic MATa derivative of JF820, to generate JF1375. JF1375 containing the pBG28 reporter plasmid was then transformed with a CEN-based yeast genomic DNA library originally constructed by P. Hieter in the LEU2 vector pSB32 (constructed by J. Trueheart). Transformants arising on SC-Ura-Leu media at 30ЊC were replica plated to SC-Ura-Leu plates containing 75 mg of X-Gal per ml. TEA1 candidates were identified as blue colonies after 1 day of incubation on X-Gal medium.
DNA sequencing. A 4.0-kb XhoI-to-BbuI restriction fragment containing the TEA1 gene was isolated from pBG122 and subcloned into modified versions of pGEM-5Zf(Ϫ) and pGEM5Zf(ϩ) in which XhoI linkers were inserted at the EcoRV sites to generate pBG135 and pBG155, respectively. pBG135 and pBG155 DNA were extracted with acid-phenol to remove nicked and linear species (76), digested with SalI and NsiI (pBG135) or BbuI and XbaI (pBG155), and then treated, as described in the Promega ''Protocols and Applications Guide,'' with exonuclease III (New England Biolabs) and S1 nuclease to generate unidirectional deletions. Single-stranded DNA was prepared from pBG135 and pBG155 deletion derivatives by using M13K07 helper phage and used as a template for sequencing. Sequencing reactions were performed by using the Sequenase sequencing kit (version 2.0; United States Biochemical Corporation), primers complementary to the SP6 and T7 promoter sequences flanking the insert, and [
35 S]dATP (Amersham). Reaction products were resolved on 6% acrylamide (19:1 acrylamide/bisacrylamide) sequencing gels containing 7 M urea. Sequencing data were compiled by using GelStart from the University of Wisconsin Genetics Computer Group package (24) .
Hybridization. Hybridization conditions for the yeast chromosome blot have been previously described (25) . Lambda prime clone grid filters (56) were provided by L. Riles and M. Olson and hybridized as recommended in the accompanying literature.
Probes were prepared by random prime labeling (20, 21) . A 1.2-kb TEA1 PstI fragment from pBG135 was used in evaluating TEA1 message size. The chromosome and lambda prime clone grid filters were hybridized with a 3.1-kb XhoI-XbaI fragment from pBG135.
Oligonucleotides. Oligonucleotides were prepared by S. Brown (Department of Biological Sciences, University of Iowa) with an Applied Biosystems DNA synthesizer except where noted otherwise. Oligonucleotides used for sequencing analysis included a GST oligonucleotide (5Ј-tgcctggatgcgttccc-3Ј) (gift from R. Deschenes, Department of Biochemistry, University of Iowa) and a Gal4 DBD oligonucleotide (5Ј-gagtagtaacaaaggtc-3Ј).
Base pair changes were introduced by site-directed mutagenesis into fragment D and into the TEA1 gene as previously described (27) . The changes were screened by sequence analysis and replaced into the pLG⌬312 vector (D mutants) or pGEX-KG GST vector (TEA1 derivative) (28) GST-Tea1 purification. E. coli MC1061 carrying plasmid pBG187 or control vector pGEX-KG (28) was grown and induced with isopropylthiogalactopyranoside (IPTG) essentially as described previously (22) . GST fusion proteins were purified by previously described methods (61) , with minor modifications. Briefly, pelleted cells were washed and resuspended in phosphate-buffered saline (PBS)-dithiothreitol (DTT) (140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 10 mM DTT) and incubated with 1 mg of lysozyme per ml on ice for 1 h. Lysis was accomplished by incubating cells for 1 min in a sonicating water bath (4ЊC) and then for 1 h on ice. Cell debris was pelleted by centrifugation at 10,000 ϫ g (4ЊC). The supernatant was incubated with glutathione-Sepharose (Pharmacia) for 30 min at 6ЊC. Sepharose beads were collected by centrifugation and washed five times with 5 ml of PBS-DTT. Protein-bound beads were resuspended in an equal volume of thrombin cleavage buffer (50 mM Tris-HCl [pH 8 .0], 150 mM NaCl, 2.5 mM CaCl 2 , 0.1% ␤-mercaptoethanol) containing 2.5 U of thrombin (Sigma) per ml and incubated for 30 min at room temperature with gentle mixing. Following cleavage, the supernatant was collected and the beads were washed once with an equal volume of 2ϫ storage buffer ( GST-Tea1 fusion protein isolated from pBG189, a derivative of the yeast GST vector pKGEST (51) , was induced by addition of 2% galactose to cells grown in glycerol-ethanol medium and isolated according to published protocols (51) .
Gel mobility shift assays. Probe preparation, protein-DNA binding conditions, and electrophoretic fractionation of complexes were as described previously (27) . Approximately 2 to 20 ng of Tea1 purified from E. coli or from S. cerevisiae as a GST fusion protein and, in some cases, subsequently cleaved with thrombin as described above was added in place of crude cell extract where noted. Specific competitor DNA was added to a 75-fold molar excess.
DNase I footprinting. Ty1 fragment D was single-end-labeled with [␣- 32 P]dCTP and Klenow enzyme at either the XhoI or SalI site of pJF351 (74) and then released by digestion with a second enzyme. DNA-protein binding reaction mixtures (see above) were incubated for 15 min at 30ЊC and then treated for 1 min with 4 l of 0.12 U of RQ DNase I (Promega) per l in 50 mM CaCl 2 -50 mM MgCl 2 . Reactions were stopped by addition of 4 l of 0.2 M EDTA and were immediately subjected to polyacrylamide gel (4%) electrophoresis (27) . Bound and free DNA complexes were identified by autoradiography following a 3-h exposure to film at 4ЊC. Complexes were eluted from the acrylamide slice by incubation at 37ЊC for 5 h in 0.5 M ammonium acetate-10 mM magnesium acetate-1 mM EDTA-0.01% sodium dodecyl sulfate. The eluate was extracted once with phenol-chloroform-isoamyl alcohol (25:24:1) and ethanol precipitated. The pellet was washed once with 75% ethanol, resuspended in 50% formamide-0.01% bromophenol blue, boiled for 2 min, and then loaded on a 10% sequencing gel. Gels were dried and subjected to PhosphorImager analysis (Molecular Dynamics model 445 SI PhosphorImager and ImageQuant software).
Nucleotide sequence accession number. The GenBank accession number of the TEA1 sequence is U37696.
RESULTS
Isolation of tea mutants. To isolate mutations in genes required for transcriptional activation by the Ty1 enhancer-like element, wild-type strain JF820, carrying the fragment D-driven reporter gene UAS(Ty1-D)-CYC1-lacZ on plasmid pBG28, was subjected to ethyl methanesulfonate mutagenesis. pBG28 transformant colonies of JF820 are typically blue on media containing X-Gal. A total of 90 mutants exhibiting a white or pale blue phenotype on X-Gal medium were identified by this screen. Eighteen of these mutants contained cisacting mutations in the reporter plasmid. The white phenotype of the remaining 72 mutants was unlinked to the reporter plasmid.
Since mutations in MCM1 and RAP1 had previously been shown to reduce fragment D-mediated activation (27) , each mutant was transformed with MCM1 and RAP1 clones. Ten mutants were complemented by a RAP1 plasmid, and one mutant was complemented by an MCM1 plasmid. These mutants were not studied further.
The remaining mutants were tested for effects on Ty-mediated adjacent gene expression. The lys2-61 Ty insertion mutation was introduced into the mutants on a plasmid. The lys2-61 allele is a cold-sensitive Ty insertion mutation in which LYS2 transcription is abolished at 16ЊC, causing a Lys Ϫ phenotype. A low level of Ty-mediated LYS2 transcription at 30ЊC is sufficient for lysine prototrophy (65) . Since mutations in the RAP1 and MCM1 genes which encode known fragment D activators mildly alter lys2-61 expression (27, 74) , mutations in other fragment D regulators were expected to exhibit similar effects. Of the 61 mutants tested, 34 showed altered lys2-61 expression. These mutants showed one of three phenotypes: (i) reduced growth on media lacking lysine at 30ЊC, similar to the effect of mutations in RAP1 (27) ; (ii) mild suppression of the coldsensitive lysine auxotrophy as is seen in spt mutants (19) ; and (iii) reduced growth at 30ЊC plus increased growth at 16ЊC (a combination of phenotypes i and ii). Two mutants (mutants 19 and 58) also suppressed a lys2-128␦ insertion mutation.
Linkage analysis. Since the presence of the a1-␣2 diploid control sites in fragment D (Fig. 1 ) complicated our ability to use complementation analysis to examine relationships among the mutants, linkage analysis was used instead. The 34 mutants exhibiting altered adjacent gene expression were backcrossed to wild-type strain JF821. Twenty-three mutants showed clear 2:2 segregation of the X-Gal phenotype in dissected tetrads. MATa and MAT␣ derivatives of most mutants were crossed by one another to establish linkage relationships. Linkage analysis revealed 4 groups (linkage group 1 [LG1] to LG4) with more than one allele and a maximum of 11 additional linkage groups.
LG1 Table 3 ).
All seven class 4 mutants fell into LG1. Mutants 6 and 37 exhibited a 25-fold reduction in fragment D-mediated activation (Table 3 ). The magnitudes of the effect on fragment Dmediated activation were similar in three of the remaining five mutants; the other two showed weaker effects (data not shown). The gene defined by the mutations in strains of LG1 was designated TEA1, and the mutant alleles were renamed to reflect their original mutant designations (e.g., mutant 6 became tea1-6).
Isolation and characterization of the TEA1 gene. The TEA1 gene was cloned by complementation of the X-Gal phenotype (white) of the tea1-6 mutant. The mutant strain, JF1375, carrying the UAS(Ty1-D) reporter was transformed with a lowcopy-number genomic library. Ten complementing clones were isolated from among 12,000 library transformants. Restriction analysis of these clones identified a common region of approximately 5.5 kb within the insert sequences (pBG122 and pBG127 in Fig. 2, for example) . Subfragments of this region were subcloned into the yeast shuttle vector pRS315 (64) and tested for complementation of the mutant phenotype. A 3.1-kb XhoI-XbaI fragment was sufficient for complementation (pBG156 in Fig. 2) .
To confirm that the 3.1-kb XhoI-XbaI fragment encoded the TEA1 gene, a tea1-6/tea1⌬::LEU2 diploid was constructed (the tea1⌬ construct, pBG161, and its phenotype are described below). The mutant phenotype (white on X-Gal plates) of the diploid strongly suggests that the disrupted locus identifies TEA1. Sporulation of the diploid yielded no progeny with a blue X-Gal phenotype among 12 complete tetrads. To map the TEA1 gene to the physical map, the 5.3-kb XhoI-HindIII fragment from pBG127 ( Analysis of the null mutant reveals a small contribution of TEA1 to normal Ty1 levels in the cell. To construct a TEA1 deletion allele with which to disrupt the genomic TEA1 locus, a ScaI fragment encompassing Tea1 aa 64 to 566 was deleted from pBG135, and the LEU2 gene was inserted to generate pBG161 (Fig. 2) . pBG161 was digested with XhoI and XbaI, and the linear fragment was transformed into JF820 containing the UAS(Ty1-D)-lacZ reporter. Integrants were white on XGal plates. tea1⌬ mutants were characterized by the same 25-fold decrease in UAS(Ty1-D) reporter activity as the original tea1-6 mutant (data not shown).
Deletion of the TEA1 gene had no apparent effect on the growth rate of haploid yeast cells under standard growth conditions, use of nonfermentable carbon sources, or growth in synthetic media. Mating and sporulation efficiencies were also unaffected. The mutant showed no sensitivity to high-salt conditions or temperature extremes and no hypersensitivity to cadmium or cycloheximide. The tea1 mutation did not suppress the negative effect on adjacent gene expression caused by the lys2-128␦ insertion mutation or the lys2-61 Ty1 insertion mutation at the LYS2 locus or by the his4-917 Ty2 insertion mutation at the HIS4 locus.
To examine the role of Tea1 in modulating Ty levels, RNA was prepared from strains lacking or overexpressing the gene. Using a Ty1 probe, Ty levels (the Ty1 probe hybridizes to both Ty1 and Ty2 RNAs) were reduced modestly (25 to 40%) in TEA1 deletion strains and increased twofold in strains overexpressing TEA1 (data not shown). Likewise, the activity of a Ty1-lacZ fusion plasmid containing the N-terminal 1,225 bp of a Ty1 element which includes fragment D was reduced twofold in TEA1 deletion strains (Fig. 3A) (5) . Consistent with the modest effect on Ty1 levels due to the absence of Tea1, a perceptible loss in Ty-mediated LYS2 expression was seen in tea1⌬ strains containing the lys2-61 Ty1 insertion mutation (19, 65) . lys2-61 mutants are Lys Ϫ at room temperature but Lys ϩ at 30ЊC, presumably because of the presence of Ty1 sequences in the LYS2 promoter. The absence of TEA1 reduced the extent to which media lacking lysine could support the growth of colonies at 30ЊC (Fig. 3B) .
TEA1 sequence. Sequencing of the 3.1-kb XhoI-XbaI fragment containing TEA1 revealed one large open reading frame (ORF) of 777 aa. The first ATG occurs 54 bp into the ORF; hence, the predicted Tea1 protein is 759 amino acids long and has a molecular mass of 86.9 kDa (Fig. 4) . The 2.7-kb TEA1 message is of adequate size to encode the predicted 759-aa ORF. A search of several databases by using the University of Wisconsin Genetics Computer Group software (24) as well as the National Center for Biotechnology Information BLAST software confirmed that the TEA1 gene had not previously been identified.
A consensus TATAAA element is present at position Ϫ93 relative to the first ATG of the ORF (67) . A putative transcription initiation site (consensus PuPuPyPuPu) located 57 bp downstream of the TATAAA element falls within the expected window (40 to 120 bp downstream of the TATA element) for initiation (30, 33) . Two potential GCN4 binding sites (Ϫ264 and Ϫ126) and a perfect match to the enhancer core of the DNA tumor virus SV40 (Ϫ144) (71) were also found. Consensus RNA splicing motifs were not detected (59) .
ORFs were also identified both upstream and downstream of the TEA1 gene (Fig. 2) . Sequences corresponding to the C-terminal 64 aa of the KRE5 gene were found upstream of the TEA1 locus. The predicted protein encoded by the downstream ORF initiating 275 bp beyond the TEA1 stop codon does not correlate with proteins in existing databases.
The N terminus of the deduced Tea1 protein sequence is highly related to the zinc cluster DBD found at the amino termini of a small family of fungal transcription factors including Gal4, Ppr1, Put3, and NirA, among others (3, 45, 52, 53, 57) . This Tea1 domain (aa 69 to 98) conforms well to the consensus sequence for zinc cluster DBDs (47) . A region with potential to form three heptad repeats of an amphipathic ␣ helix was found 14 aa C terminal (aa 113 to 133) to the putative DBD. On the basis of the deduced crystal structures of Gal4 (46) and Ppr1 (47) , this region is predicted to mediate ho- (38) . Several clusters of acidic residues are apparent in the predicted Tea1 protein; the C-terminal 48-aa acidic domain (net charge, Ϫ10) has the highest density of negatively charged residues. Site of action of Tea1. The TEA1 gene was identified on the basis of its effect on fragment D of Ty1 elements. To further refine the site of action, the response of lacZ reporters directed by D subfragments H and I (Fig. 1) to TEA1 was evaluated. The activity of the UAS(Ty1-H)-CYC1-lacZ reporter was unaffected by mutation or overexpression of TEA1, whereas the activity of the UAS(Ty1-I)-CYC1-lacZ reporter decreased 11-fold in the tea1 mutant and increased 3.7-fold in a strain overexpressing the TEA1 gene ( Table 4 ). The I fragment contains a binding site for the Rap1 protein and sequences protected by the IBF protein or protein complex (9, 27) .
The majority of fungal zinc cluster proteins recognize a CGGN x CCG partially palindromic sequence (26, 57, 63) . Several potential recognition sites for zinc cluster proteins were identified in Ty1 fragment D, one with a spacing of 10 (N 10 ), a second with N 5 spacing, and a third with N 29 spacing. The four CGG (or CCG) boxes are labeled a to d in Fig. 1 . Mutation of box a was previously tested and found to have a large effect on fragment D-mediated activation (D* I in reference 27). The D* Ia mutant was originally constructed to test the requirement for IBF binding in fragment D-mediated activation and consists of a C3A change in the CGG repeat and a T3C change three bases upstream of the C. These positions were selected for mutation on the basis of their strong protection in DNase footprinting experiments (9) . Mutation in box b also reduced fragment D-mediated activation; however, mutation of box c had no effect (Table 4) . Since box d coincides with the Rap1 binding site, it was not tested. Boxes a and b are separated by 10 bp and hence suggest a CGGN 10 CCG recognition site.
DNA binding. The binding of Tea1 to this site was examined by electrophoretic gel mobility shift assay. Recombinant Tea1 was used in these experiments since we have been unable to detect Tea1 DNA-binding activity in crude extracts. A recombinant, affinity-purified Tea1 (aa 3 to 232) fragment including the putative DBD and dimerization domain (released from a GST fusion by thrombin treatment) formed a specific complex with a radiolabeled Ty1 fragment D probe (Fig. 5) . Complex formation was inhibited by the addition of unlabeled fragment D with or without a mutation in CGG repeat c but was not inhibited by addition of unlabeled fragment D containing a mutation in CGG repeat a or b (Fig. 5) (27) . Similar results were obtained with a recombinant full-length Tea1 (aa 3 to 759)-GST fusion protein produced in S. cerevisiae (data not shown). Both the DBD fragment of Tea1 (Fig. 6 ) and the full-length GST-Tea1 (data not shown) protected the two CGG repeats as well as the intervening sequence in DNase I footprinting experiments.
Activation. To examine the capacity of Tea1 for transactivation, fusions of portions of Tea1 to the DBD from Gal4 (aa 1 to 147) were tested for the ability to activate a lacZ reporter driven by four Gal4 binding sites in the context of the GAL1 UAS. The stability of the Gal4-Tea1 fusions used in this analysis was confirmed by Western blot (immunoblot) analysis using a Gal4 antibody (Upstate Biotechnology Inc.; affinity purified by D. Mallin and P. Geyer, University of Iowa). Fusion of the intact Tea1 (aa 3 to 759) to the Gal4 DBD (pBG201) increased activity greater than 500-fold relative to the Gal4 DBD alone (Fig. 7) . The C-terminal 56 aa encoding the acidic VOL. 16, 1996 ANALYSIS OF Tea1, A YEAST Ty ENHANCER-BINDING PROTEIN 353
at Penn State Univ on April 17, 2008 mcb.asm.org domain of Tea1 (aa 704 to 759) conferred a similar level of activation when fused to the Gal4 DBD (pBG202). Consistent with a role for this domain in activation, a truncation of Tea1 (aa 3 to 704) which lacks the C-terminal acidic domain (pBG203) eliminated activation ( Fig. 7) and Tea1 function (pBG181 in Fig. 2) . In contrast to the full-length Tea1 (aa 3 to 759), fusion of an N-terminal truncation of Tea1 which lacks the Tea1 DBD (aa 270 to 759) to the Gal4 DBD (pBG176) showed no significant increase in activity over a Gal4 DBD construct with no added Tea1 sequences (Fig. 7) . The failure of Tea1 sequences to activate in the absence of the Tea1 DBD suggests the involvement of the DBD in activation. Alternatively, or in addition, the C-terminal activation domain could be subject to inhibition by central Tea1 sequences in the absence of the Tea1 DBD. From the results of the Gal4 fusions shown in Fig. 7 , Tea1 aa 270 through 666 were postulated to contain an inhibitory activity. The low activity of a chimera (pBG199) consisting of the Gal4 DBD, the central region of Tea1 (aa 270 to 704), and the well-characterized Gal4 activation domain (aa 767 to 881) (43) is consistent with the presence of an inhibitory domain in Tea1 (Fig. 7) . The putative inhibitory domain appears to be at least partially neutralized by the combined presence of the Tea1 DBD and activation domain.
The relationship between Tea1 and other CGGN 10 CCGbinding proteins. Tea1 recognizes a CGG repeat motif with a spacing of 10 bp. Put3, a zinc cluster DNA-binding protein required for the activation of proline-inducible genes, recognizes sites with the same spacing (63) . To test whether Put3 can interact with the Tea1 site in fragment D, strains were transformed with a high-copy-number PUT3 plasmid. Since Put3 activity is induced by proline (1), reporter activity was tested under two growth conditions: standard (ammonia is available as a nitrogen source) and proline (proline is provided as the sole nitrogen source). The Put3 protein recognized the Tea1 binding site on Ty1 fragment D because overexpression of PUT3 (under proline growth conditions) increased fragment D-mediated activation two-to threefold both in the presence and in the absence of Tea1 (data not shown).
To examine the normal interplay between Tea1 and Put3, UAS(Ty1-D)-lacZ activities were compared in strains containing or lacking the PUT3 gene. Deletion of the PUT3 gene had no effect on fragment D-mediated activation. These measurements were made in standard growth conditions, since the PUT3 gene is required for growth on proline media. Hence, Put3 makes no contribution to the activity of the Ty1 fragment D enhancer. The lack of PUT3 contribution to fragment D activity indicates that Tea1 and Put3 have distinct transcriptional activities despite recognizing the same sequence motif.
DISCUSSION
Isolation of Ty enhancer-binding proteins. Previous efforts to identify the trans-acting factors responsible for Ty and Tymediated gene expression have led to a collection of factors that exert global effects on the process of transcription. This may be due to the complexity and redundancy of Ty regulatory signals. In our screen for mutations affecting the Ty1 enhancerlike elements included on restriction fragment D, we have succeeded in identifying a hitherto unknown DNA-binding protein involved in transcriptional activation of Ty1 elements. The approach (considering only small clusters of sites at a time) that we took to identify transcriptional regulators that interact with Ty element enhancers is further justified since deletion of the TEA1 gene causes only very subtle effects on Ty1 and Ty1-mediated gene expression. Hence, screening criteria used in the previous studies (4, 11, 18, 72, 73) were unlikely to have led to the identification of the TEA1 gene.
The TEA1 gene probably encodes IBF. Tea1 is a zinc cluster DNA-binding protein that recognizes a CGG inverted repeat motif with a spacing of 10 bp. This site is located adjacent to (Fig. 5 ).
In addition, the previously observed IBF footprint (9) includes the region of Ty1 fragment D protected from DNase I digestion by Tea1 binding. The direct test of this hypothesis, examining the IBF footprint in tea1 mutants, has proven difficult, since we have been unable to detect an IBF complex or footprint in crude extracts. In contrast to the IBF footprint (Fig. 1) , the Tea1 footprint (determined by using either the DBD fragment [GST free] or the full-length GST-Tea1 fusion protein) was restricted to the CGGN 10 CCG motif. The difference in the extents of the IBF and Tea1 footprints implies the presence of additional proteins in the IBF complex. However, the possibility that the attached GST sequences interfere with Tea1 binding has not been ruled out.
Tea1 is a transcriptional activator of Ty elements and may regulate additional genes. The predicted Tea1 protein has a small C-terminal domain of approximately 50 aa that is noteworthy for its net negative charge. The importance of this domain was demonstrated by the inability of TEA1 subclones lacking this region to complement the low UAS(Ty1-D)-CYC1-lacZ reporter activity of a tea1 mutant. Consistent with the role of this domain in transcriptional activation was the large increase in GAL1-lacZ reporter activity that resulted upon fusion of the domain to the Gal4 DBD. In its native context, the activity of the Tea1 acidic domain appears to be VOL. 16, 1996 ANALYSIS OF Tea1, A YEAST Ty ENHANCER-BINDING PROTEIN 355
at Penn State Univ on April 17, 2008 mcb.asm.org dependent on the Tea1 DBD. The DBD may contribute a specific residue or an acidic face, or it may be required for generating a folded conformation in which the acidic domain of Tea1 is optimally aligned with other proteins. It is unlikely that the Tea1 DBD itself constitutes an independent activation domain, since all C-terminal truncations lacking the C-terminal acidic activation domain fail to complement a tea1 mutation (see Fig. 2 for one example). A contribution of DBDs to activation has been previously noted in the yeast zinc finger transcription factor Adr1, the yeast zinc cluster transcription factor Hap1, and the mammalian glucocorticoid receptors (10, 36, 60) . To evaluate the possible involvement of Tea1 in regulation of transcription of genes in addition to Ty1 elements, S. cerevisiae sequences in the GenBank and EMBL databases were screened for the presence of CGG repeats with a spacing of 10 bp located upstream of coding regions; 42 previously characterized genes were identified. Several of the genes identified, including ARGRIII, CAR2, CPA1, and ARG3, are involved in arginine metabolism. Expression of ARGRIII and ARG3 was measured in collaboration with E. Dubois and, in preliminary experiments, found to be unaffected by the absence or overexpression of TEA1. The absence of a TEA1 effect on ARGRIII and ARG3 expression may reflect the existence of additional CGGN 10 CCG repeat-binding proteins and/or a requirement for Tea1 interactions with auxiliary regulatory proteins, binding sites for which are present in Ty1 fragment D but not necessarily in other candidate TEA1-regulated genes.
Possible regulation of Tea1 activity. The central region of the Tea1 protein (aa 270 to 666) inhibits the activity of the Gal4 activation domain (Gal4 aa 768 to 881). Constructs consisting of the Gal4 DBD plus this Gal4 activation domain and no intervening sequences typically exhibit 50% of the transactivation of the full Gal4 protein (43) . When Tea1 sequences (aa 270 to 666) were interposed between the two Gal4 domains, the activity was reduced to less than 1% of that of Gal4 (Fig. 7) . Since inhibition is apparent in molecules dependent on the heterologous Gal4 DBD, it seems likely that activation and not DNA binding is affected by the Tea1 inhibitory domain. However, the yeast Hap1 protein is an example of a zinc cluster protein with an inhibitory domain that exerts an effect on a heterologous DBD by interfering with Hap1 dimerization (29) . Hence, the possibility that the central sequences of Tea1 inhibit DNA binding cannot be excluded. Importantly, the presence of an inhibitory domain in Tea1 suggests that Tea1 activity (or DNA binding) is regulated. Although the activity of Tea1 is apparent under standard glucose growth conditions, it is possible that the activity of the protein is further increased in the presence of an unknown inducer. Alternatively, Tea1 activity may be downregulated under alternative growth conditions or in response to some other environmental stimulus.
Tea1 and Put3 have distinct activities. The Tea1 protein is related to Put3 by a number of criteria. The two proteins are organized similarly, with an N-terminal zinc cluster DBD and adjacent dimerization domain and a C-terminal activation domain (45) . Each transcription factor recognizes a CGGN 10 CCG element. Our experiments indicate, however, that the Put3 protein does not normally contribute to the activity of fragment D. It is possible that the Put3 and Tea1 proteins have different affinities for the CGGN 10 CCG site. A number of subtle differences in the Put3 and Tea1 DBDs could account for hypothetical differences in affinity. For example, the region between the Zn 2 Cys 6 DBD and the coiled-coil dimerization domain (linker) is 14 aa in Tea1 and 15 aa in Put3. The importance of differences in linker length and sequence to protein conformation and to DNA binding specificity and affinity is known from comparison of the crystal structures of different zinc cluster proteins (46, 47) and by studies of chimeras (55) . In addition, Put3 has an unusual histidine residue 4 aa downstream from the second conserved cysteine, whereas Tea1 has a conserved arginine residue at that position (47) . Alternatively, Tea1 and Put3 may bind equivalently to the fragment D site in vitro but exhibit differences in the ability to interact with the neighboring Rap1 protein in vivo.
Downstream regulation of Ty transcription by the Tea1 and Rap1 proteins. Tea1 is an example of a yeast DNA-binding protein with the potential to regulate transcription from a downstream position. Mutations in the TEA1 gene led to reduced levels of Ty transcription (Fig. 3) . Although the Tea1 binding site that we studied, located 649 bp downstream of the Ty1 initiation site, may not be the only site in Ty1 elements, no Tea1 binding sites were identified in Ty1 sequences upstream of the initiation site. The position of the Rap1 binding site within fragment D of the Ty1 element enhancer, the absence of Rap1 binding sites in the Ty1 promoter, and the decreased level of Ty transcription in rap1 mutants suggests that Rap1 
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at Penn State Univ on April 17, 2008 mcb.asm.org also has the ability to regulate gene expression in S. cerevisiae from a downstream position (27) . Regulation of Ty1 transcription from a downstream position by Rap1 is consistent with studies of several glycolytic genes in which downstream Rap1 binding sites have also been identified (16, 49, 54) and whose absence may account for the striking reductions in transcript levels seen when these gene promoters are fused to heterologous coding regions. Although the Tea1 and Rap1 binding sites can be defined as downstream transcriptional regulatory motifs, our studies do not address whether the Tea1 and Rap1 (and possibly Mcm1) binding sites are sufficient to encode downstream enhancer activity. It is possible that some unique feature of Ty1 elements (and other genes with downstream activation elements) will provide a necessary context within which certain transcription factors may mediate downstream activation. Future studies in which the activity of Ty1 fragment D is tested in heterologous contexts will be required to address this point.
TEA1 overexpression substitutes for general transcription factors. Surprisingly, the TEA1 gene was reisolated during our attempts to clone the gene corresponding to a class 1 mutant which is unlinked to TEA1. The general transcriptional defect of this mutant (3-to 10-fold reductions in levels of activity of all reporters tested) was not alleviated by extra copies of the TEA1 gene; however, a CEN-based plasmid carrying TEA1 fully complemented the reduction in UAS(Ty1-D)-CYC1-lacZ activity. The UAS(Ty1-D)-CYC1-lacZ reporter defects of several other (but not all) class 1 linkage groups were similarly complemented by the TEA1 clone. Our studies indicate that overexpression of the TEA1 gene on both low-and high-copynumber plasmids in wild-type cells significantly increased UAS(Ty1-D)-CYC1-lacZ activity as well as Ty1 levels (Table  4) . Hence, the suppression of a general transcription defect by extra copies of the TEA1 gene suggests that a small increase in Tea1 protein levels in the cell alleviates the requirement of Ty1 element transcription for a number of general transcription factors defined by the class 1 linkage groups. The eventual identification of those components of the general transcription apparatus that become dispensable in the presence of extra Tea1 may provide insight into the mechanism of transcriptional activation by downstream regulators.
